CCDC120抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Hela cell lysate, Primary antibody: P02469(CCDC120 Antibody) at dilution 1/800, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 40 seconds    

  
  

The CCDC120 antibody targets the Coiled-Coil Domain Containing 120 (CCDC120) protein, a less characterized member of the coiled-coil domain-containing protein family. These proteins typically participate in cellular processes like cytoskeletal organization, intracellular transport, and cell division through their coiled-coil domains. CCDC120 is speculated to play roles in cellular structural maintenance or signaling, though its exact biological functions remain under investigation. Studies suggest potential links to cancer progression, as aberrant expression of CCDC120 has been observed in certain tumors, implicating it in cell proliferation or metastasis.

The CCDC120 antibody is primarily used in research to detect and quantify CCDC120 expression in tissues or cell lines via techniques like Western blotting, immunohistochemistry (IHC), or immunofluorescence (IF). It aids in elucidating the protein's localization, expression patterns, and interactions with other molecules. Commercial antibodies are often raised in rabbits or mice, validated for specificity using knockout controls or siRNA-mediated knockdown.

Current research focuses on clarifying CCDC120's role in disease mechanisms, particularly cancer, and its potential as a diagnostic or prognostic biomarker. Further studies are needed to unravel its molecular pathways and therapeutic relevance. The antibody remains a critical tool for advancing understanding of CCDC120's contributions to cellular physiology and pathology.